Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Q2 2022 Takeda Pharmaceutical Co Ltd Earnings Press Conference Transcript

Oct 28, 2021 / 08:00AM GMT
Release Date Price: €24.68 (+1.56%)
Takako Ohyabu
Takeda Pharmaceutical Company Limited - Chief Global Corporate Affairs Officer

Thank you very much for taking time out of your busy schedule to participate in today's conference call for the press on our financial results for the second quarter of fiscal year 2021. I will be moderating the call today. My name is Takako Ohyabu, Chief Global Corporate Affairs Officer. Thank you very much for joining us.

First, I'd like to explain about the language setting. In the lower right corner of Zoom webinar, there is a language setting button, a globe sign. And this is the under setting button. Click on it. And then select Japanese if you want to listen in Japanese, and select English if you want to listen to English. And if you'd like to listen original voice, without interpretations, please select off. If you [can't] ask a question during the Q&A sessions, please set your zoom display name to your name and affiliation.

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot